Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Control for Pain Following Percutaneous Nephrolithotomy
NCT05024344Recruiting
- Sponsor
- University of Tennessee Medical Center
- Start
- Aug 2021
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine and dexamethasone in postoperative pain (2 arms), sponsored by University of Tennessee Medical Center. Primary endpoint: Opioid consumption (MME) at 24 hours. Started Aug 2021; status: recruiting.
02
Drugs
ropivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05024344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05024344.